Clinical Trial: A Study to Assess the Safety of ARGX-213 in Healthy Volunteers

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968338) titled 'A Study to Assess the Safety of ARGX-213 in Healthy Volunteers' on May 05.

Brief Summary: This study aims to assess the safety of ARGX-213 in healthy adults. Another aim is to measure the amount of ARGX-213 in the blood over time to learn how it moves through the body and acts in the body. The participants will remain in the study for approximately up to 21 weeks.

Study Start Date: April 11

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: BIOLOGICAL: ARGX-213

Intravenous or subcutaneous administrations of ARGX-213

OTHER: Placebo

Intravenous or subcutaneous administrations of placebo

Recruitment Status:...